Otsuka’s H1 Pharma Sales Rise 12% on Global Brands, Profits Drop 26.2%

August 1, 2022
Otsuka Holdings’ pharmaceutical revenue in January-June grew 12.0% year on year with major contributions from its four global brands, while business profit in the segment slid 26.2% due to temporary factors. In the first half of 2022, the company’s pharma...read more